Distinct glioma subtypes, grades, or stages may exhibit unique expression patterns, with earlier studies reporting reduced CAT activity likely examining different tumor populations than those characterized by overexpression in aggressive phenotypes [130,146]. The gene discussed is CAT; the disease is central nervous system cancer.